Need for neck dissection after radiochemotherapy? A study of the French GETTEC group

Laryngoscope

Volumn 118, Issue 10, 2008, Pages 1775-1780

  Vedrine, Pierre Olivier ^a   Tharia, Juliette ^b,i   Hitier, Martin ^c   Janot, Francois ^d   Kaminsky, Marie Christine ^e   Makeieff, Marc ^f   De Raucourt, Dominique ^c   Lapeyre, Michel ^g   Toussaint, Bruno ^h  

^a Cannes Hospital   (France)

^b Anti Cancer Centre Lacassagne   (France)

^c CENTRE FRANÇOIS BACLESSE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e CENTRE ALEXIS VAUTRIN   (France)

^f MONTPELLIER UNIVERSITY HOSPITAL   (France)

^g CENTRE JEAN PERRIN   (France)

^h UNIVERSITY HOSPITAL OF NANCY   (France)

ⁱ CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Carcinoma; Head and neck; Morbidity; Neck dissection; Radiochemotherapy; Response; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX TUMOR; INOPERABLE CANCER; LARYNX TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MORBIDITY; MOUTH TUMOR; NECK DISSECTION; OROPHARYNX TUMOR; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SURGICAL PATIENT; TREATMENT RESPONSE; CLINICAL TRIAL; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; SURVIVAL RATE;

EID: 53449084496     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31817f192a     Document Type: Article

References (18)

1. Brizel DM, Prosnitz RG, Hunter S., et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004; 58:1418-1423.
2. Mendenhall WM, Million RR, Cassisi NJ. Squamous cell carcinoma of the head and neck treated with radiation therapy: the role of neck dissection for clinically positive neck nodes. Int J Radiat Oncol Biol Phys 1986; 12:733-740.
3. Argiris A., Stenson KM, Brockstein BE, et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004; 26:447-455.
4. Yovino S., Settle K., Taylor R., et al. Can adjuvant neck dissection be deferred in locally advanced head neck cancer patients with complete response to definitive chemoradiotherapy? Int J Radiat Oncol Biol Phys 2007; 69:S15.
5. Narayan K., Crane CH, Kleid S., Hughes PG, Peters LJ. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999; 21: 606-613.
6. Boyd TS, Harari PM, Tannehill SP, et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck 1998; 20:132-137.
7. Davidson BJ, Newkirk KA, Harter KW, Picken CA, Cullen KJ, Sessions RB. Complications from planned, posttreatment neck dissections. Arch Otolaryngol Head Neck Surg 1999; 125:401-405.
8. Clayman GL, Johnson CJ II, Morrison W., Ginsberg L., Lippman SM. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg 2001; 127:135-139.
9. McHam SA, Adelstein DJ, Rybicki LA, et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer? Head Neck 2003; 25:791-798.
10. Stenson KM, Haraf DJ, Pelzer H., et al. The role of cervical lymphadenectomy after aggressive concomitant chemo radiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000; 126:950-956.
11. Peters LJ, Weber RS, Morrison WH, Byers RM, Garden AS, Goepfert H. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996; 18:552-559.
12. Zhou J., Goenka A., Garg R., et al. Optimal management of the neck in patients with locoregionally advanced oropharyngeal carcinoma: comparison of pre-radiotherapy neck dissection, post-radiotherapy neck dissection or observation. Int J Radiat Oncol Biol Phys 2007; 69:S414-S415.
13. Grabenbauer GG, Rodel C., Ernst-Stecken A., et al. Neck dissection following radiochemotherapy of advanced head and neck cancer-for selected cases only? Radiother Oncol 2003; 66:57-63.
14. Thariat J., Ahamad A., Garden AS, et al. Prediction of neck dissection (ND) requirement following definitive radiotherapy (RT) for head and neck squamous cell carcinoma (HNSCC). Int J Radiat Oncol Biol Phys 2006; 66:S17-S18.
15. Newkirk KA, Cullen KJ, Harter KW, Picken C., Sessions R., Davidson B. Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck 2001; 23:73-79.
16. Lavertu P., Adelstein DJ, Saxton JP, et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997; 19:559-566.
17. Greven KM, Williams DW III, McGuirt WF Sr, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck 2001; 23:942-946.
18. Yao M., Graham MM, Hoffman HT, et al. The role of postradiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2004; 59:1001-1010.